#

Terns Pharmaceuticals

: 5
Freedom Broker has looked at which small caps in the biotech space were most popular among hedge funds in the fourth quarter / Photo: Shutterstock.com
Small Caps·
Up to 840% upside: 10 smid-cap biotechs most popular with hedge funds
Shares of Terns rose about 6% on the announcement / Photo: Unsplash / Julia Koblitz
Small Caps·
Merck to buy mid-cap biotech Terns, but William Blair thinks the price tag is low
Lindblad Expeditions partners with National Geographic to organize expeditions and trips, and its quotes have risen 26% since the beginning of the year / Photo: Facebook / Lindblad Expeditions
Small Caps·
Freedom looks at top small-cap holdings among hedge funds; most are below $20 a share
Freedom names best and worst small cap performers from last week
Small Caps·
Freedom names best and worst small cap performers from last week
Small caps that can challenge Novo Nordisk and Eli Lilly in the obesity drug market
Small Caps·
Small caps that can challenge Novo Nordisk and Eli Lilly in the obesity drug market